Blend Labs Inc (BLND) concluded trading on Thursday at a closing price of $4.44, with 6.86 million shares of worth about $30.45 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 59.71% during that period and on November 07, 2024 the price saw a gain of about 15.03%. Currently the company’s common shares owned by public are about 240.26M shares, out of which, 189.54M shares are available for trading.
Stock saw a price change of 22.31% in past 5 days and over the past one month there was a price change of 26.86%. Year-to-date (YTD), BLND shares are showing a performance of 74.12% which increased to 200.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.16 but also hit the highest price of $4.25 during that period. The average intraday trading volume for Blend Labs Inc shares is 2.83 million. The stock is currently trading 22.23% above its 20-day simple moving average (SMA20), while that difference is up 21.52% for SMA50 and it goes to 46.63% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Blend Labs Inc (NYSE: BLND) currently have 240.26M outstanding shares and institutions hold larger chunk of about 38.15% of that.
The stock has a current market capitalization of $1.13B and its 3Y-monthly beta is at 1.17. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 8.46% while standing at 6.35% over the month.
Stock’s fiscal year EPS is expected to rise by 82.05% while it is estimated to increase by 171.52% in next year. EPS is likely to grow at an annualized rate of 20.00% for next 5-years, compared to annual growth of -19.48% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Canaccord Genuity on August 12, 2024 offering a Buy rating for the stock and assigned a target price range of between $3 and $4.75 to it. On December 20, 2023, Wells Fargo Upgrade their recommendations, while on November 14, 2022, Keefe Bruyette Upgrade their ratings for the stock with a price target of $2.25. Stock get an Underperform rating from Keefe Bruyette on July 25, 2022.
